These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18045061)

  • 41. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts.
    Lee YC; Huang CF; Murshed M; Chu K; Araujo JC; Ye X; deCrombrugghe B; Yu-Lee LY; Gallick GE; Lin SH
    Oncogene; 2010 Jun; 29(22):3196-207. PubMed ID: 20228840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of Src in solid tumors.
    Wheeler DL; Iida M; Dunn EF
    Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
    Chong YP; Ia KK; Mulhern TD; Cheng HC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines.
    Santucci MA; Corradi V; Mancini M; Manetti F; Radi M; Schenone S; Botta M
    ChemMedChem; 2009 Jan; 4(1):118-26. PubMed ID: 19039816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families.
    Krisch LM; Posselt G; Hammerl P; Wessler S
    Infect Immun; 2016 Sep; 84(9):2671-80. PubMed ID: 27382024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Src-family tyrosine kinases, phosphoinositide 3-kinase and Gab1 regulate extracellular signal-regulated kinase 1 activation induced by the type A endothelin-1 G-protein-coupled receptor.
    Bisotto S; Fixman ED
    Biochem J; 2001 Nov; 360(Pt 1):77-85. PubMed ID: 11695994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation.
    Shishido T; Akagi T; Ouchi T; Georgescu MM; Langdon WY; Hanafusa H
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6439-44. PubMed ID: 10829062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
    Gomes EG; Connelly SF; Summy JM
    Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.
    Fabbro D; Manley PW; Jahnke W; Liebetanz J; Szyttenholm A; Fendrich G; Strauss A; Zhang J; Gray NS; Adrian F; Warmuth M; Pelle X; Grotzfeld R; Berst F; Marzinzik A; Cowan-Jacob SW; Furet P; Mestan J
    Biochim Biophys Acta; 2010 Mar; 1804(3):454-62. PubMed ID: 20152788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the activity of SRC and Abl tyrosine protein kinases by the binding of the Wiskott-Aldrich syndrome protein.
    Schulte RJ; Sefton BM
    Biochemistry; 2003 Aug; 42(31):9424-30. PubMed ID: 12899629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606.
    Mancini M; Brusa G; Zuffa E; Corrado P; Martinelli G; Grafone T; Barbieri E; Santucci MA
    Leuk Res; 2007 Jul; 31(7):979-87. PubMed ID: 17129604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacology of Src family kinases and therapeutic implications of their modulators.
    Kumar A; Jaggi AS; Singh N
    Fundam Clin Pharmacol; 2015 Apr; 29(2):115-30. PubMed ID: 25545125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
    Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus.
    Newsome TP; Weisswange I; Frischknecht F; Way M
    Cell Microbiol; 2006 Feb; 8(2):233-41. PubMed ID: 16441434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
    Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.
    Huang H; Ma J; Shi J; Meng L; Jiang H; Ding J; Liu H
    Bioorg Med Chem; 2010 Jul; 18(13):4615-24. PubMed ID: 20570525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region.
    Moroco JA; Baumgartner MP; Rust HL; Choi HG; Hur W; Gray NS; Camacho CJ; Smithgall TE
    Chem Biol Drug Des; 2015 Aug; 86(2):144-55. PubMed ID: 25376742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway.
    Encinas M; Tansey MG; Tsui-Pierchala BA; Comella JX; Milbrandt J; Johnson EM
    J Neurosci; 2001 Mar; 21(5):1464-72. PubMed ID: 11222636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment.
    Cui Z; Li X; Li L; Zhang B; Gao C; Chen Y; Tan C; Liu H; Xie W; Yang T; Jiang Y
    Bioorg Med Chem; 2016 Jan; 24(2):261-9. PubMed ID: 26707846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts.
    Piera-Velazquez S; Jimenez SA
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):36-44. PubMed ID: 30277861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.